Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for AVANDIA
- Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
- Rosiglitazone Adjunctive Therapy for Severe Malaria in Children
- Effects of Rosiglitazone and Metformin on Metabolism in Type 2 Diabetes
- Insulin Resistance and Mild Cognitive Impairment (IRMCI) Study
- Identification of Null Allelic Variant of CYP2C8 In A Korean Population
- Effects of Rosiglitazone and Alpha-lipoic Acid on the Patients With Pathologically Proved NASH
- A Study to Assess the Effect Tasimelteon on the Cytochrome P450 3A4 and 2C8 Enzymes in Healthy Subjects
- Effect of Rosiglitazone on the Vascular Biology of Human Fat Tissue
- A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors
- Role of Insulin Action and Free Fatty Acids in Hyperandrogenism of Women With Polycystic Ovary Syndrome
- Thiazolidinedione Intervention With Vitamin D Evaluation
- A Study for Pre-diabetic Patients With Cholesterol Lowering Drugs
- Rosiglitazone And Fenofibrate Additive Effects on Lipids (RAFAEL)
- Insulin Resistance and Intramyocellular Lipid Content in Glucose Intolerant Subjects Receiving Rosiglitazone
- Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C Infections
- Bone Turnover in Type 2 Diabetes Patients
- Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)
- Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes Patients
- Study In Postmenopausal Women With Type 2 Diabetes Looking At Approved Diabetes Drugs And How They Affect Bone Health
- Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study
- EMPOWIR:Enhance the Metabolic Profile of Women With Insulin Resistance
- The Use of Rosiglitazone to Treat Asthma
- The Effect of Glitazone Treatment on Bone Marrow and Bone Marrow Cells
- Dietary Fatty Acids as Complementary Therapy in Type 2 Diabetes Mellitus
- Effect of Thiazolidinedione Treatment Vascular Risk Markers
- Gene Regulation by Thiazolidinediones
- Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801)
- Comparison of the Efficacy and Tolerability of the Addition of AVANDIA to Submaximal Doses of Metformin
- Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL Study
- Effects of Colesevelam HCl, Rosiglitazone, Sitagliptin on Control of Blood Glucose and Lipids in Type 2 Diabetes Patients Whose Blood Glucose Isn't Completely Controlled With Metformin
- Predictive Markers of Glitazone Efficacy in Diabetic Patients - Pilot Study
- Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocardial Triglyceride
- Effects of Rosiglitazone on the Metabolic Phenotype of Impaired Glucose Tolerance in Youth
- 11ß-HSD1 and Metabolic Syndrome
- Rosiglitazone Maleate in Treating Patients With Oral Leukoplakia
- Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)
- AVANDIA With Glyburide In African American And Hispanic Patients With Type 2 Diabetes Not Controlled by Glyburide Alone
- Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia
- The Effect Of AVANDIA On The Late Asthmatic Response
- Examining the Effect of Different Diuretics on Fluid Retention in Diabetics Treated With Rosiglitazone.
- Beta Cell Function Tests Over Time In Patients With T2dm Randomized To Metformin Or Rosiglitazone
- Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
- Insulin Resistance in Patients With Mood Disorder
- Rosiglitazone Effects on Cognition for Adults in Later Life
- Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin
- Study In Patients With Insulin Resistance
- Preferred Treatment of Type 1.5 Diabetes
- Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS)
- Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.
- Rosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate Cancer
- Vein-Coronary Atherosclerosis And Rosiglitazone After Bypass Surgery: The VICTORY Trial
- Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling Glucose
- Rosiglitazone (Avandia®) Treatment in HIV: Its Effect on Blood Vessels
- An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus
- Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin (AVALANCHE™ Study)
- Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance
- Effect of Rosiglitazone on Peritoneal Cytokines in Women With Endometriosis
- Study Of AVANDAMET® With Or Without Insulin In Type II Diabetes Mellitus Patients. AVANDAMET® is a Registered Trademark of the GSK Group of Companies.
- A Trial of Rosiglitazone for Ulcerative Colitis
- Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)
- Rosiglitazone and Exercise Training: Effects on HIV-Infected People With Insulin Resistance, Hypertriglyceridemia, and Adipose Tissue Maldistribution
- Underlying Abnormalities in Fat and Muscle Leading to Lipodystrophy Syndrome
Clinical trials list
click for details